6-Bromohexanoyl chloride

We are 6-Bromohexanoyl chloride CAS:22809-37-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:   6-Bromohexanoyl chloride
CAS.NO:22809-37-6
Synonyms:
6-bromohexanoic chloride
6-Bromocaproyl chloride 6-Bromohexanoic acid chloride
6-Bromohexanoic acid chloride
6-Bromocaproyl chloride
6-bromo-hexanoyl chloride
Hexanoyl chloride,6-bromo
Hexanoyl chloride, 6-bromo-
6-bromo-n-hexanoyl chloride
6-Bromohexanoyl Chloride

Molecular Formula: C6H10BrClO
Molecular Weight: 213.50000

Physical and Chemical Properties:
Density: 1.395 g / mL at 25 ° C (lit.)
Boiling point: 130 ° C20 mm Hg (lit.)
Flash point:> 230 ° F
Refractive index: n20 / D 1.486 (lit.)

Specification:
Appearance:White  powder
Purity:≥98.0%
Moisture Content: ≤0.25%
Impurity: ≤0.3%

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Keep away from heat, sparks, and flame. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Corrosives area.
Application:An important raw material and intermediate used in Organic Synthesis,Pharmaceuticals.

Related News: “We will continue to closely monitor the situation and we look forward to reopening our stores as soon as possible.”2-(4-bromophenyl)triphenylene Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.Clorhidrato de 5- (piperazin-1-il) benzofuran-2-carboxilato de etilo CAS:765935-67-9 Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.Tianeptine Sodium Salt Hydrate Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.